After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its unbranded equivalent. Patients typically need about ...

In reality, patients pay much lower net prices. After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its unbranded ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Eli Lilly’s big-selling insulin, Humalog ... Lilly will be able to maintain this with the launch of Humalog, which is available in vial form or as a disposable pen. Sanofi fights back This ...

The reason a price cap is being targeted is due to the rapid increase in the cost of insulin products over the last few decades. According to research, one vial of Humalog (insulin lispro ...

28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly) 28 days Prescribing information NPH, human insulin isophane suspension (rDNA origin) Novolin N vial (Novo ...